Expansion of collagen casing production capacity and stable operations at the Fujinomiya No. 2 Plant
First written in FY2016. 11 of 23 entries say "Advanced", first in FY2017-Q1. Latest entry: 2026-08-07.
No other company in this theme has enough history to compare yet.
- 2026-08-07RestatedResults
「利益面では原材料費、人件費、エネルギー費の上昇があったものの、生産が順調であったことと輸出為替の影響から増益となりました。」
コラーゲン・ケーシング事業では生産が順調に推移し、北米向け輸出と輸出為替の影響により増益となった。 - FY2026AdvancedAnnual report
「The collagen casing business reorganized certain unprofitable production equipment and recorded an impairment loss of ¥438 million.」
Following the withdrawal from specially specified products for overseas markets whose profitability was not expected to improve in the future, the equipment was idled and an impairment loss of ¥438 million was recorded. The initiative progressed from expanding production capacity and achieving stable operations to reorganizing unprofitable equipment. - FY2026-H1ReframedAnnual report
「In the collagen casing business, the Company withdrew from producing certain specially specified products for overseas markets for which profitability was not expected to improve in the future, and recorded impairment losses on the equipment used to produce those products and on modification costs. The impairment loss recorded for the interim consolidated accounting period was ¥427 million.」
The policy shifted from the previous focus on stable operation and expansion of production capacity to withdrawing from specially specified products for overseas markets where profitability was not expected to improve and reorganizing the related equipment. An impairment loss of ¥427 million was recorded. - FY2025AdvancedAnnual report
「Although fuel, labor, and other costs increased, profit rose as production progressed smoothly and exceeded the plan. As a result, collagen casing business net sales were ¥9,328 million, down 1.8% year on year, while operating profit and segment profit were ¥1,165 million, up 20.2%.」
Collagen casing production exceeded the plan, and segment profit increased 20.2% despite higher costs. - FY2021AdvancedAnnual report
「Although export sales remained in a difficult environment due to the resurgence of infectious diseases overseas and other factors, profitability improved through ongoing price revisions and lower manufacturing costs in the manufacturing division. As a result, collagen casing business net sales were ¥8,268 million, down 13.7% year on year, operating profit was ¥1,034 million, up 14.1%, and segment profit was ¥1,034 million, up 55.7%.」
Although net sales declined, profitability improved due to price revisions and lower manufacturing costs, and segment profit was ¥1,034 million, up 55.7% year on year. - FY2021-Q3AdvancedAnnual report
「Although domestic sales were sluggish, particularly for foodservice products such as frankfurters, profitability improved due to the effects of price revisions in overseas sales and lower manufacturing costs. As a result, net sales were ¥6,142 million, down 18.6% year on year, operating profit was ¥750 million, down 6.4%, and segment profit was ¥750 million, up 22.0%.」
Domestic and overseas sales declined, but profitability improved due to price revisions in overseas sales and lower manufacturing costs, and segment profit increased 22.0% year on year. - FY2021-Q2AdvancedAnnual report
「Export sales performed steadily while competing with overseas companies and pursuing earnings improvement. On the production side, profitability improved as manufacturing costs declined. As a result, net sales were ¥4,161 million, down 17.7% year on year, operating profit was ¥492 million, down 8.5%, and segment profit was ¥492 million, up 20.7%.」
In the collagen casing business, profitability of overseas sales improved and manufacturing costs declined. Although net sales decreased, segment profit increased 20.7% year on year. - FY2021-Q1AdvancedAnnual report
「On the production side, earnings improved as manufacturing costs declined. As a result, net sales were ¥2,236 million, down 13.5% year on year, operating profit was ¥403 million, up 58.8%, and segment profit was ¥403 million, up 113.6%.」
In the collagen casing business, earnings improved as manufacturing costs declined, and segment profit increased from ¥188 million in the same quarter of the previous year to ¥403 million. - FY2020AdvancedAnnual report
「In the manufacturing division, production efficiency improved substantially and costs declined. As a result, collagen casing business net sales were ¥9,585 million, up 3.7% year on year, operating profit was ¥906 million, compared with an operating loss of ¥108 million in the previous consolidated fiscal year, and segment profit was ¥664 million, compared with a segment loss of ¥800 million in the previous consolidated fiscal year.」
Across the production structure, including the Fujinomiya No. 2 Plant, substantial improvements in production efficiency and cost reductions progressed, turning operating and segment losses into profits. - FY2020-Q3AdvancedAnnual report
「Domestic sales remained in a difficult situation despite various efforts to expand sales. Export sales continued to pursue earnings improvement while competing on price with overseas companies. On the production side, production efficiency improved substantially and costs continued to decline. As a result, net sales were ¥7,548 million, up 2.7% year on year, operating profit was ¥801 million, compared with an operating loss of ¥162 million in the same quarter of the previous year, and segment profit was ¥614 million, compared with a segment loss of ¥674 million.」
In the collagen casing business, substantially improved production efficiency reduced costs, and the business turned from an operating loss and segment loss in the same quarter of the previous year to operating profit of ¥801 million and segment profit of ¥614 million. - FY2020-Q1AdvancedAnnual report
「On the production side, manufacturing costs declined due to improved production efficiency. As a result, net sales were ¥2,586 million, up 0.3% year on year, operating profit was ¥254 million, up 6,966.0%, and segment profit was ¥188 million, compared with a segment loss of ¥165 million in the same quarter of the previous year.」
In the collagen casing business, improved production efficiency reduced manufacturing costs, and the business turned from a segment loss to a segment profit. - FY2019WorsenedAnnual report
「In the manufacturing division, operating rates declined and production costs rose due to inventory adjustments and natural disasters, in addition to depreciation at the new plant. As a result, collagen casing business net sales were ¥9,242 million, up 5.6% year on year, operating loss was ¥108 million, compared with operating profit of ¥775 million in the previous consolidated fiscal year, and segment loss was ¥800 million, compared with segment profit of ¥123 million in the previous consolidated fiscal year.」
Depreciation at the new plant, inventory adjustments, and natural-disaster-related lower operating rates resulted in an operating loss and segment loss for the year, with conditions concerning stable operations after the production capacity expansion deteriorating further. - FY2019-Q3Depreciation at the new plant, inventory adjustments, and natural disasters reduced operating ratesAnnual report
「In addition to depreciation at the new plant, manufacturing operating rates declined due to inventory adjustments and the effects of natural disasters in the summer, causing production costs to rise. As a result, net sales were ¥7,349 million, up 7.0% year on year, operating loss was ¥162 million, compared with operating profit of ¥872 million in the same quarter of the previous year, and segment loss was ¥674 million, compared with segment profit of ¥381 million.」
In the collagen casing business, operating rates declined and production costs rose due to depreciation at the new plant, inventory adjustments, and natural disasters in the summer. Although net sales increased, the business reported an operating loss and a segment loss. - FY2019-Q2Natural disasters reduced operating rates and worsened profitabilityAnnual report
「Manufacturing struggled as operating rates declined substantially due to lightning damage in the summer, typhoons, and prolonged rain, while the depreciation burden of the new plant added to the pressure. As a result, net sales were ¥4,896 million, up 10.6% year on year, operating loss was ¥213 million, compared with operating profit of ¥565 million in the same quarter of the previous year, and segment loss was ¥551 million, compared with segment profit of ¥217 million.」
In the collagen casing business, lower operating rates caused by lightning, typhoons, and prolonged rain were compounded by the depreciation burden of the new plant. Although net sales increased, the business reported an operating loss and a segment loss. - FY2019-Q1Depreciation at the new plant squeezed profitabilityAnnual report
「Although export sales increased as a result of measures to expand sales, profitability declined substantially due to intense price competition and the depreciation burden of the new plant. As a result, net sales were ¥2,578 million, up 15.1% year on year, operating profit was ¥3 million, down 98.8%, and the segment reported a loss of ¥165 million, compared with segment profit of ¥144 million in the same quarter of the previous year.」
Collagen casing export sales increased, but profitability declined substantially due to the depreciation burden of the new plant and price competition, resulting in a segment loss. - FY2018RestatedAnnual report
「The Company made capital investments for the construction of a new plant and the replacement of machinery and equipment, mainly equipment requiring regular replacement. Capital investment totaled ¥504 million.」
The collagen casing business has continued to invest in plants and machinery and equipment. This was described as an effort to maintain and strengthen the production structure following the start of full-scale operations at the Fujinomiya No. 2 Plant. - FY2017AdvancedAnnual report
「During the current consolidated fiscal year, the Group focused on securing new domestic and overseas customers and on sales activities in each business segment, including the collagen casing business, where a full-scale production expansion structure had been established at the Fujinomiya No. 2 Plant, as well as gelatin, peptides, cosmetics, and leather. Alongside expanding sales, it worked to strengthen its earnings structure.」
The disclosure stated that the Fujinomiya No. 2 Plant had progressed from stable operations to a full-scale production expansion structure. Capital investment in the collagen casing business during the fiscal year totaled ¥504 million. - FY2017-Q3RestatedAnnual report
「The Group had traditionally used mainly the declining-balance method to depreciate its tangible fixed assets, excluding lease assets, but changed to the straight-line method from the first quarter of the current consolidated fiscal year. This change followed a review of the depreciation method prompted by the start of full-scale operations at the Collagen Casing Fujinomiya No. 2 Plant. Stable future demand is expected for the products manufactured there, and the principal production equipment is expected to operate stably over its future useful life. Accordingly, the Group determined that the revised method was reasonable for reflecting the allocation of costs more appropriately in profit or loss. As a result of this change, depreciation expense for the nine-month period of the current consolidated fiscal year decreased by ¥359 million compared with the previous method, while operating profit, ordinary profit, and profit before income taxes for the nine-month period increased by ¥359 million.」
The change to the straight-line method prompted by the start of full-scale operations at the Fujinomiya No. 2 Plant and its ¥359 million impact for the nine-month period were reconfirmed. - FY2017-Q2RestatedAnnual report
「This change followed a review of the depreciation method prompted by the start of full-scale operations at the Collagen Casing Fujinomiya No. 2 Plant. Stable future demand is expected for the products manufactured there, and the principal production equipment is expected to operate stably over its future useful life. Accordingly, the Group determined that the revised method was preferable for reflecting the allocation of costs more appropriately in profit or loss.」
The start of full-scale operations at the Fujinomiya No. 2 Plant and the resulting change in the depreciation method, based on expectations for stable product demand and stable operation of the principal production equipment, were reiterated. - FY2017-Q1AdvancedAnnual report
「The Group had traditionally used mainly the declining-balance method to depreciate its tangible fixed assets, excluding lease assets, but changed to the straight-line method from the first quarter of the current consolidated fiscal year. This change followed a review of the depreciation method prompted by the start of full-scale operations at the Collagen Casing Fujinomiya No. 2 Plant. Stable future demand is expected for the products manufactured there, and the principal production equipment is expected to operate stably over its future useful life. Accordingly, the Group determined that the straight-line method was preferable for reflecting the allocation of costs more appropriately in profit or loss.」
For the Fujinomiya No. 2 Plant, the disclosure changed from the previous year's focus on completion and stable operations to the start of full-scale operations and the expectation of stable future operations. - FY2016First statedAnnual report
「In the collagen casing business, the Company will work to ensure stable operations at the newly established Fujinomiya No. 2 Plant.」
The Fujinomiya No. 2 Plant was completed in May 2016, and capital investment in the business totaled ¥4,798 million. The Company is working to stabilize supply capacity through the expanded production lines.